Ai Feedback
Exact(7)
In multivariate analysis, diabetes, proteinuria and hypertension were the strongest determinants of CKD 3+.
In multivariate analysis, diabetes was the only significant predictor (aHR: 3.14).
In multivariate analysis, diabetes was found to influence Hb towards a higher level (p = 0.004) and EPO requirements towards lower doses (p = 0.0004).
In multivariate analysis, diabetes duration, cardiovascular disease, and particularly the degree of albuminuria were independently associated with endothelial progenitor cell number.
In the multivariate analysis, diabetes (Beta = −0.27, P = 0.03) and age (Beta = −0.27, P = 0.02) had a significant association with decreased MPR.
On multivariate analysis, diabetes mellitus without end-organ complications (OR 2.87 [1.09-7.08]), connective tissue disease (OR 7.22 [1.17-44.59]), and liver failure (OR 8.39 [1.55-45.45]) were independent risk factors for carriage of an ESBL-E upon admission to hospital (area under the ROC curve, 0.68).
Similar(53)
In multivariate analysis, smoking, diabetes mellitus and log FGF23 were each identified as risk factors for CAAC.
In multivariate analysis, however, diabetes was associated with a higher risk of primary and secondary outcome only in women (Table 5).
In multivariate analysis, gestational diabetes was associated with maternal intrapartum infection [OR 4.3 (95 % CI 1.7-11.0, p = 0.002] and early epidural analgesia with neonatal clinical sepsis [OR 10.5 (95 % CI 1.4-76 1.4-760.02].
In a multivariate logistic regression analysis diabetes duration was the only reported factor independently associated with a history of diabetic retinopathy.
Reports had to specify the proportion (numerator and denominator) of subjects seroprotected by diabetes status (or data available that allowed for calculation of the proportions), or available odds ratios from a multivariate analysis, which included diabetes as a predictor variable.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com